Navigation Links
Charleston Laboratories, Inc. Phase I Clinical Trial
Date:1/12/2009

Charleston begins Bioequivalence Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CL-108

CHARLESTON, S.C., Jan. 12 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company dedicated to reducing opioid induced nausea and vomiting (OINV) in opioid pharmaceuticals, announced today the initiation of a pharmacokinetic study on its first drug candidate, CL-108. "After many months' development in the lab, resulting in the optimal formulation of this drug, it is ready for testing in man," said Dr. Bernard Schachtel, Chief Medical Officer at Charleston Laboratories. "This Phase I study is being conducted to identify and characterize the release characteristics of CL-108, showing its differences (and similarities) to comparator drugs. We expect that the in-vivo results from this study will confirm the in-vitro results on CL-108, which can be advanced to the Phase III efficacy and safety trial we discussed with the FDA at our Pre-IND Meeting."

In fact, Dr. Schachtel added, "When the results of the Phase I study are available (in early 2009), Charleston Labs will be ready to test the efficacy and safety of CL-108 in patients with acute pain. Charleston Labs' Phase III study on CL-108 is already in the planning stages," he said. "Clinical investigators have been selected at major U.S. universities to conduct this large study beginning in 2009."

"We are looking forward to achieving the expected results of our fast dissolving low dose anti-emetic," said Paul Bosse, Chief Executive Officer at Charleston Laboratories. "CL-108 is the first of many planned therapeutic products Charleston is advancing into clinical studies." Reaching this exciting milestone is a testament of perseverance and dedication by the entire Charleston team."

All clinical studies for Charleston Laboratories are being overseen by SRC, Inc., a contract research organization base
'/>"/>

SOURCE Charleston Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study
2. The Hope Clinic in Charleston, SC invests in technology to prevent vision loss in patients
3. Charleston, S.C., Market Integration Likely to Drive Physician Groups to Seek Health System Affiliation
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
7. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
8. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
9. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
10. Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... genetic finding from Duke Medicine suggests that some people ... also be hard-wired to gain weight when exposed to ... An estimated 13 percent of people, all of whom ... this could help them reduce heart disease with simple ... management. , "Genetic susceptibility, psychosocial stress and metabolic factors ...
(Date:10/1/2014)... 2014 Between 23 million and 50 ... according to figures from the National Institutes of Health ... and many of them have something else in common: ... celiac disease. Gluten Free Therapeutics, makers of CeliVites ... celiac disease by publishing a series of blog posts ...
(Date:10/1/2014)... Jersey City, NJ (PRWEB) October 01, 2014 ... sticking with their intentions to lose weight and their dieting ... in unhealthy, fatty foods. Including hormone diet treatments ... not only allows patients to see fast and effective weight ... diet and begin forming healthy habits to maintain their weight ...
(Date:10/1/2014)... Anti Aging Clinic (AntiAgingClinic.ca), the Greater Toronto ... choice, is announcing a discounted cost on Botox units, ... “We’re doing this because we want to give as ... clinic in Toronto,” says Dr. Brian Sieber, founder of ... Aging Clinic, including laser facials, genesis laser facials, ...
(Date:10/1/2014)... 01, 2014 On Sept. 9, Chapín ... in the Martha Stewart American Made Awards (MSAMAs), an ... the country in the fields of crafts, design, food ... as a finalist in the MSAMAs, which celebrates entrepreneurs ... are improving local communities and changing the way we ...
Breaking Medicine News(10 mins):Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2
... Mich. The University of Michigan Cardiovascular Center, a ... national clinical trial to offer patients a less invasive ... nationally ranked U-M is among 40 sites in the ... a study that will examine an investigational alternative to ...
... are caused by abnormal neural activity of the basal ... are connected to the cerebral cortex in the brain ... connections, as well as the dysfunctions in movement disorders, ... the other hand, little is known about the human ...
... , WEDNESDAY, March 9 (HealthDay News) -- ... teachers who feel disrespected by colleagues -- have been ... in students, according to a new study. ... challenges directly cause mental health problems in kids. However, ...
... American Journal of Epidemiology that despite the high level ... England, Americans experience higher rates of chronic disease and markers ... health status differs so dramatically in these two countries, which ... mystery. The study uses data from two nationally representative ...
... BROOK, Ill. March 8, 2011 In recognition ... GIE: Gastrointestinal Endoscopy has published a special issue ... includes a study showing that colonoscopy has prevented a ... many more could have been prevented with more widespread ...
... 8, 2011 In recognition of National Colorectal Cancer ... has put out a special issue for March on ... first statement from a new initiative by the American ... Incorporation of Valuable Endoscopic Innovations (PIVI). The first PIVI ...
Cached Medicine News:Health News:University of Michigan Cardiovascular Center studies new treatment for high-risk aortic patients 2Health News:University of Michigan Cardiovascular Center studies new treatment for high-risk aortic patients 3Health News:Classroom Environment May Affect Kids' Mental Health 2Health News:Americans have higher rates of most chronic diseases than same-age counterparts in England 2Health News:Colonoscopy linked to decrease in colorectal cancer deaths, but many more could have been prevented 2Health News:Colonoscopy linked to decrease in colorectal cancer deaths, but many more could have been prevented 3Health News:Colonoscopy linked to decrease in colorectal cancer deaths, but many more could have been prevented 4Health News:ASGE initiative examines real-time endoscopic assessment of the histology of diminutive colorectal polyps 2Health News:ASGE initiative examines real-time endoscopic assessment of the histology of diminutive colorectal polyps 3Health News:ASGE initiative examines real-time endoscopic assessment of the histology of diminutive colorectal polyps 4Health News:ASGE initiative examines real-time endoscopic assessment of the histology of diminutive colorectal polyps 5
(Date:10/1/2014)... 2014 Quantum Materials Corp (OTCQB:QTMM) today ... photoactive quantum dots for use in next-generation ... advantages for solar power generation, the high cost ... dots with which to develop thin film solar ... utilization and acceptance. The company is also seeking ...
(Date:10/1/2014)... 2014 Sophia Genetics, leader ... de l,analyse des données issues du SNG (séquençage ... diagnostic in vitro (IVD) du gène CFTR permettant ... mucoviscidose dans un seul essai SGN. La solution ... types de variantes par l,intermédiaire d,un seul essai ...
(Date:9/30/2014)... 2014  Hologic, Inc. (NASDAQ: HOLX ), ... and Chief Executive Officer, will preside over the NASDAQ ... first day of Breast Cancer Awareness Month. In his ... on the important benefits of Hologic,s 3D Mammography technology, ... clinically superior to traditional mammography. This is ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... a company leading the scientific research of neurogenesis using ... novel pathways for the treatment of central nervous system ... from the Broad Institute of MIT and Harvard and ... its scientific advisory board. The appointees join BrainCells, advisory ...
... 20 Ferring Pharmaceuticals presented an interim study analysis ... in in vitro fertilization (IVF) cycles using ... in a poster at the 65th Annual Meeting of ... October 17-21, 2009. , MENOPUR® vs. ...
Cached Medicine Technology:BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman 2BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman 3Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles 2Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles 3
Philadelphia™ Collar - Plastazote® with plastic anterior and posterior reinforcements. Hook-and-pile closure straps. Chin cradle reduces rotation. Occipital and mandibular pieces may be int...
... a lightweight patient friendly brace utilizing the latest ... The Escort provides patients with a lightweight brace ... Superior comfort and improved patient compliance is the ... Escort Hip brace is the result of a ...
... Management Systems are designed and engineered to ... your patients. Innovative new options increase function ... on the most successful patented features of ... clamping disk design and the tremendous versatility ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
Medicine Products: